Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 91 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 7572448

    Combined cancer treatment methods using selected antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  2. US 7566714

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  3. US 7563446

    Methods and compositions for inducing autoimmunity in the treatment of cancers

    The Board of Regents of the University of Texas System · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted

  4. US 7557081

    Alpha-1-acid glycoprotein for the treatment of diabetes

    Essential Skincare, LLC · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  5. US 7550617

    Compositions and methods for the treatment of renal and cardiovascular disease

    The Board of Regents of the University of Texas System · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  6. US 7550454

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    ACADIA Pharmaceuticals Inc. · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  7. US 7544358

    Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

    The Regents of the University of California · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  8. US 7541040

    Chimeric molecule for the treatment of th2-like cytokine mediated disorders

    The United States of America as represented by the Department of Health and Human Serivces · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  9. US 7541035

    Immunogenic peptides for the treatment of prostate and breast cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  10. US 7541331

    Surfactant treatment regimen

    Discovery Laboratories, Inc. · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  11. US 7534440

    Fusion molecules and methods for treatment of immune diseases

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted

  12. US 7531570

    Treatment of diseases using ICE inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  13. US 7521049

    Use of VEGF inhibitors for treatment of eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  14. US 7517871

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    ACADIA Pharmaceuticals Inc. · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  15. US 7501494

    Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    United Biomedical, Inc. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  16. US 7501260

    Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment

    Precision Therapeutics, Inc. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  17. US 7491715

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    ACADIA Pharmaceuticals Inc. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  18. US 7488804

    Modified fusion molecules for treatment of allergic disease

    The Regents of the University of California · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  19. US 7482002

    Method of administering and using VEGF inhibitors for the treatment of prostate cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  20. US 7482331

    Diagnosis and treatment of myocardial failure

    The Regents of the University of Colorado · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  21. US 7479273

    Method of administering and using VEGF inhibitors for the treatment of renal cell cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  22. US 7479275

    Method of administering and using VEGF inhibitors for the treatment of colorectal cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  23. US 7479274

    Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  24. US 7479272

    Method of administering and using VEGF inhibitors for the treatment of breast cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.